Doreen M. Reich

Doreen M. Reich, PhD, HCP, is a seasoned professional in drug safety and pharmacovigilance, currently serving as a Senior Safety Scientist at Ultragenyx Pharmaceutical Inc. since June 2018. With previous experience at Medivation as a Drug Safety Manager and at Onyx Pharmaceuticals as a Drug Safety Associate, Doreen has developed a robust skill set in adverse event processing, regulatory compliance, and safety management. Academic credentials include a combined Masters Diploma in Biology and related fields from the University of Leipzig and a training program in clinical trials management at San Francisco State University. Doreen's career also includes significant contributions as a Pharmacovigilance Scientist at the Coordination Center for Clinical Trials in Berlin, involving complex safety data analysis and collaboration with regulatory agencies.